AKT1 and neuroblastoma: Although the response to radiotherapy remains untested in NB, the identified IGF1R-kinase signaling (STAT3/AKT)-CSC/EMT mechanistic logic aligns with the NPC axis, demonstrating a shared dependence on IGF1R-driven downstream pathways to sustain resistance phenotypes (65).